Kane Biotech Files New Patent on Latest Breakthrough
Canada based Kane Biotech Inc. is all set to increase its sales market and hit the biotechnology global market with a bang as it files its new patent. This new patent is reportedly based on the bone tissue regeneration product.
The Winnipeg Company Kane Biotech Inc's filed for a new patent and said that once the new patent is approved, the invention will basically cover the development of a distinctive combination result using the Company's CSP technology to help breed bone cells by enhancing bone cell binding and bone tissue regeneration.
Mr. Gord Froelich, Kane Biotech's President and Chief Executive Officer (CEO), said that once the new patent is approved, the invention can also be used to repair dental bone defects, fractures and for even the possible prevention of osteoporosis.